These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23472943)

  • 1. Gene expression profiles of cumulus cells obtained from women treated with recombinant human luteinizing hormone + recombinant human follicle-stimulating hormone or highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone alone.
    Gatta V; Tatone C; Ciriminna R; Vento M; Franchi S; d'Aurora M; Sperduti S; Cela V; Borzì P; Palermo R; Stuppia L; Artini PG
    Fertil Steril; 2013 Jun; 99(7):2000-8.e1. PubMed ID: 23472943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of gene expression profiles in granulosa and cumulus cells after ovulation induction with either human chorionic gonadotropin or a gonadotropin-releasing hormone agonist trigger.
    Borgbo T; Povlsen BB; Andersen CY; Borup R; Humaidan P; Grøndahl ML
    Fertil Steril; 2013 Oct; 100(4):994-1001. PubMed ID: 23856575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related miRNome landscape of cumulus oophorus cells during controlled ovarian stimulation protocols in IVF cycles.
    Dell'Aversana C; Cuomo F; Longobardi S; D'Hooghe T; Caprio F; Franci G; Santonastaso M; Colacurci N; Barone S; Pisaturo V; Valerio D; Altucci L
    Hum Reprod; 2021 Apr; 36(5):1310-1325. PubMed ID: 33454781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
    Carone D; Caropreso C; Vitti A; Chiappetta R
    J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.
    Lehert P; Kolibianakis EM; Venetis CA; Schertz J; Saunders H; Arriagada P; Copt S; Tarlatzis B
    Reprod Biol Endocrinol; 2014 Feb; 12():17. PubMed ID: 24555766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of neither recombinant nor urinary luteinizing hormone was associated with an improvement in the outcome of autologous in vitro fertilization/intracytoplasmatic sperm injection cycles under regular clinical settings: a multicenter observational analysis.
    Schwarze JE; Crosby JA; Zegers-Hochschild F
    Fertil Steril; 2016 Dec; 106(7):1714-1717.e1. PubMed ID: 27678033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 years.
    Bielfeld AP; Schwarze JE; Verpillat P; Lispi M; Fischer R; Hayward B; Chuderland D; D'Hooghe T; Krussel JS
    Reprod Biomed Online; 2024 Jun; 48(6):103725. PubMed ID: 38593745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis.
    Hill MJ; Levens ED; Levy G; Ryan ME; Csokmay JM; DeCherney AH; Whitcomb BW
    Fertil Steril; 2012 May; 97(5):1108-14.e1. PubMed ID: 22365075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
    Baer G; Loumaye E
    Curr Med Res Opin; 2003; 19(2):83-8. PubMed ID: 12740151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study.
    Cruz M; Requena A; Agudo D; García-Velasco JA
    Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():124-133. PubMed ID: 28622634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
    Bühler KF; Fischer R; Verpillat P; Allignol A; Guedes S; Boutmy E; Bilger W; Richter E; D'Hooghe T
    Reprod Biol Endocrinol; 2021 Jun; 19(1):90. PubMed ID: 34134695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type of gonadotropin during controlled ovarian stimulation affects the endocrine profile in follicular fluid and apoptosis rate in cumulus cells.
    Requena A; Cruz M; Agudo D; Pacheco A; García-Velasco JA
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():142-6. PubMed ID: 26751823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct healthcare cost analysis of recombinant LH versus hMG supplementation on FSH during controlled ovarian hyperstimulation in the GnRH-antagonist protocol.
    Chang JC; Yi YC; Chen YF; Guu HF; Kung HF; Chen LY; Chuan ST; Chang YM; Chen MJ
    Arch Gynecol Obstet; 2024 Feb; 309(2):699-706. PubMed ID: 38099955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH): recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35-40 years: A German database study.
    Bielfeld AP; Schwarze JE; Verpillat P; Lispi M; Fischer R; Hayward B; Chuderland D; D'Hooghe T; Krussel JS
    Best Pract Res Clin Obstet Gynaecol; 2023 Jul; 89():102350. PubMed ID: 37320996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation.
    Koloda Y; Korsak V; Rozenson O; Anshina M; Sagamonova K; Baranov I; Yakovenko S; D'Hooghe T; Ershova A; Lispi M
    Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):134-148. PubMed ID: 35216907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.